Use of New Antiviral IV Drug for H1N1 Approved by FDA








By Ed Martinez

October 25, 2009


Peramivir becomes the first FDA-approved intravenously (IV) administered antiviral for the treatment of influenza.


The approval was in response to a request from the U.S. Centers for Disease Control and Prevention. The FDA reviewed scientific data on peramivir and concluded that it can now be used in certain hospitalized adult and pediatric patients with confirmed or suspected H1N1 influenza.


The emergency use of this drug is authorized only for patients who are clinically appropriate candidates for IV therapy and for whom oral or inhaled therapies are not feasible or have failed. 

 

Web-Exclusive Featured

Aviation

technology

Automotive

Entertainment

Science

History & Technology

Comments






image verification





 
Share

ADVERTISEMENT

Follow on
Facebook

Subscribe to
RSS Feed

Follow on
Twitter

Sign Up for Newsletter

Stay up-to-date

Related Stories